SCHEMBL27033894

SCHEMBL27033894

CCn1c2nc(=O)n(C)c(=O)c-2nc2cc(C)c(C)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ GLA P06280 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ GSR P00390 7/20 0.44
▸ MAPT P10636 4/20 0.43
▸ HTT P42858 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ IDO1 P14902 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HSF1 Q00613 2/20 0.43
▸ POLB P06746 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ GALK1 P51570 3/20 0.42
▸ BLM P54132 3/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30387533 0.87 TDP2 (0.45) KDM4ESMN1; SMN2ALDH1A1GSRMAPT
SCHEMBL16476446 0.84 KDM4E (0.43) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
SCHEMBL19415772 0.84 KDM4E (0.43) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
SCHEMBL14399199 0.84 SMN1; SMN2 (0.58) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
Iodide SCHEMBL17254512 0.83 KDM4E (0.43) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
SCHEMBL864708 0.80 KDM4E (0.43) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
SCHEMBL16479714 0.78 KDM4E (0.46) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
SCHEMBL11307834 0.78 SMN1; SMN2 (0.48) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
SCHEMBL864002 0.77 MAPT (0.44) KDM4ESMN1; SMN2ALDH1A1GLAHPGD
SCHEMBL14335594 0.77 CYP1A2 (0.48) KDM4ESMN1; SMN2ALDH1A1GLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188117-A1 C-Terminal Peptide Modification TECHNISCHE UNIVERSITEIT DELFT (NL) 2025-06-12 — — US disclosed
US-20240199686-A1 C-Terminal Peptide Modification TECHNISCHE UNIVERSITEIT DELFT (NL) 2024-06-20 — — US disclosed
EP-4314007-A1 C-TERMINAL PEPTIDE MODIFICATION Technische Universiteit Delft (NL) 2024-02-07 — — EP disclosed
EP-4308582-A1 C-TERMINAL PEPTIDE MODIFICATION Technische Universiteit Delft (NL) 2024-01-24 — — EP disclosed
CN-117062825-A C-terminal peptide modification 代尔夫特科技大学 2023-11-14 — — CN disclosed
CN-117015550-A C-terminal peptide modification 代尔夫特科技大学 2023-11-07 — — CN disclosed
WO-2022203512-A1 C-TERMINAL PEPTIDE MODIFICATION TECHNISCHE UNIVERSITEIT DELFT (NL) 2022-09-29 — — WO disclosed
WO-2022197184-A1 C-TERMINAL PEPTIDE MODIFICATION TECHNISCHE UNIVERSITEIT DELFT (NL) 2022-09-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240199686-A1 C-Terminal Peptide Modification PTMS, NGLY1, QPCT KDM4E 3889/4885SMN1; SMN2 3989/4885ALDH1A1 4186/4885
US-20250188117-A1 C-Terminal Peptide Modification PTMS, NGLY1, QPCT KDM4E 4074/4885SMN1; SMN2 3782/4885ALDH1A1 3987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback